Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Ductal and Invasive Lobular Breast Carcinoma”

168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 168 results

Testing effectiveness (Phase 2)Study completedNCT02682693
What this trial is testing

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

Who this might be right for
Breast Cancer Female NOSTubular Breast Cancer Stage IIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 780
Not applicableWithdrawnNCT01960803
What this trial is testing

Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)

Who this might be right for
Invasive Ductal Breast CancerCarcinoma Breast Stage I
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Looking for participantsNCT07483307
What this trial is testing

The Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 176
Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Not applicableStudy completedNCT00321048
What this trial is testing

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Who this might be right for
Breast NeoplasmsCarcinoma, DuctalAdenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Not applicableUnknownNCT02909426
What this trial is testing

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Who this might be right for
Invasive CancerDuctal Carcinoma in Situ
Soonchunhyang University Hospital 11,880
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Not applicableWithdrawnNCT03523299
What this trial is testing

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Who this might be right for
Invasive Ductal Carcinoma, Breast
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Testing effectiveness (Phase 2)Looking for participantsNCT06540872
What this trial is testing

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Universität Münster 30
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Early research (Phase 1)Study completedNCT00290732
What this trial is testing

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableActive Not RecruitingNCT01644669
What this trial is testing

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma in Situ
Xoft, Inc. 1,200
Very early researchStudy completedNCT01796041
What this trial is testing

Intraoperative Imaging of Breast Cancer With Indocyanine Green

Who this might be right for
Invasive Ductal CarcinomaInvasive Lobular CarcinomaDuctal Carcinoma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Ended earlyNCT04252859
What this trial is testing

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Who this might be right for
Invasive Lobular Breast Carcinoma
University of Utah 44
Early research (Phase 1)Study completedNCT00749437
What this trial is testing

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 34
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT01245712
What this trial is testing

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

Who this might be right for
Breast AdenocarcinomaDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 200
Next Page